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Objectives. The aim of this prospective study of adult patients
operated with a cryopreserved aortic homograft was to use serial
echocardiographic data to evaluate the postoperative hemody-
namic performance of these valves.
Background. Only limited data on hemodynamic performance
of aortic homografts at rest and during exercise are available.
Controversy also exists regarding incidence and progression of
aortic regurgitation (AR).
Methods. Fifty-nine patients aged 39–86 years who received an
aortic homograft (median size 21 mm) implanted with sub-
coronary technique were studied with serial Doppler-
echocardiography (D-E). In 31 of these patients, D-E also was
performed during supine exercise.
Results. Overall survival was 100% during a median follow-up
of 28 months (range 4–54). During follow-up AR grade II or more
was detected in 25% of the patients with an increasing time-
related risk of developing AR. Maximum and mean pressure
differences at 7 months follow-up calculated with the short form of
the Bernoulli equation were 11.4 (4.6) and 5.5 (2.1) mm Hg,
respectively. During supine exercise that increased cardiac output
72%, maximum pressure difference increased from 11.9 (5.2) to
18.5 (9.5) mm Hg.
Conclusions. The aortic homograft valve shows low pressure
differences at rest and during exercise, but AR grade I or II is
often seen during follow-up. As AR progresses with time we stress
the importance of echocardiographic follow-up of patients with
aortic homografts.
(J Am Coll Cardiol 1998;32:1002–8)
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The use of aortic homografts for aortic valve replacement was
pioneered by Ross (1) and Barratt-Boyes (2) in the early 1960s.
Theoretically, the freehand implanted valves with preserved
aortic root function and a nonobstructed central flow offer
superior flow dynamics compared with mechanical valves or
stented bioprostheses. Clinical results with aortic homograft
valves are well documented, but currently limited data on
hemodynamic performance are available (3–11). It is known
that patients with an aortic homograft may develop various
degrees of aortic regurgitation (AR), depending on several
variables such as preservation method, structural degeneration
and implantation technique (3–11). However, controversy still
exists regarding incidence, severity and progression of AR.
The aim of this prospective study was to evaluate the
hemodynamic performance of cryopreserved subcoronarily
implanted aortic homografts, with Doppler echocardiography
(D-E) at rest and during increased flow rates induced by supine
exercise. In this study, we also present clinical results and an
analysis of the incidence and progression of AR.
Methods
The study was approved by the Committee of Ethics of
Karolinska Hospital and informed consent was obtained from
all patients.
Study patients. The study group consisted of 59 consecu-
tive patients, 33 men and 26 women with a mean age of 68
years (range 39–86), who underwent aortic valve replacement
with an aortic homograft between March 1993 and December
1996. The indication for surgery was aortic stenosis in 44
patients (75%), regurgitation in 8 (13%) and mixed lesion in 7
(12%). An aortic homograft valve was selected in cases of
absolute or relative contraindications to anticoagulant treat-
ment or if the patient expressed a strong wish to avoid
anticoagulation or a wish to receive a homograft. Preopera-
tively, 35 patients (59%) were in NYHA functional class III or
IV.
Homograft preparation. All homografts were harvested
within 24 h of donor death. The grafts were kept in 14°C
Ringer’s solution and dissected under sterile conditions at the
Homograft Bank of the Karolinska Hospital. The valves were
kept in a solution of broad-spectrum antibiotics in 250 mL
tissue culture medium 199 at 14°C for another 24 h. After
rinsing in tissue culture medium, 10% dimethyl sulfoxide was
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added and the valves were then cryopreserved at a rate of
21°C/min to 240°C. After further cooling to 2100°C the
valves were transferred to permanent storage in liquid nitro-
gen. The preparation and preservation technique has previ-
ously been described in detail by Lange and Hopkins (12).
Thawing in three consecutive 140°C baths of Ringer’s solution
was done in the operating room during the initial stage of the
operation.
Operative procedures. The operations were performed
during cardiopulmonary bypass at 32°C hypothermia. Myocar-
dial protection was accomplished with intermittent cold blood
retrograde cardioplegia via the coronary sinus. All valves were
inserted as freehand homografts in the subcoronary position
(13). We selected homografts with 2 mm less annular diameter
than that of the recipient aortic annulus, as measured at
preoperative echocardiography and/or with an obturator dur-
ing the operation. The grafts were implanted with a two-
suture-line technique without rotation and the noncoronary
sinus was not tailored down to the base of the leaflet. Inter-
rupted sutures were used proximally and a continues running
suture finished the distal suture-line. A mattress 3-0 braided
suture tied over a felt pledget on the outside of the aortic wall
was used to position the tops of the commisural pillar approx-
imately 5–10 mm downstream of the native commisural rem-
nants. One patient received a 17-mm homograft valve; 7,
patients an 18-mm valve; 8, a 19-mm valve; 9, a 20-mm valve;
14, a 21-mm valve; 4, a 22-mm valve; 9, a 23-mm valve; 2, a
24-mm valve; 4, a 25-mm valve; and 1, a 27-mm valve. The
latter patient, with a native aortic root diameter of 29 mm had
expressed a strong wish to receive a homograft. Concomitant
coronary bypass grafting was performed in 22 patients (37%),
mitral valvuloplasty in 1 patient and myectomy of the septum
in another.
Doppler echocardiography. Transthoracic Doppler echo-
cardiography was performed by one of two experienced oper-
ators (MJE or VR) using Acuson 128 XP/10 ultrasound
equipment (Mountain View, CA, USA) with 2–2.5 MHz
imaging and nonimaging transducers. The first D-E was per-
formed within one week of surgery, before hospital discharge.
Two subsequent examinations were done within the first
postoperative year and yearly thereafter. On each occasion
complete color, pulsed-wave and continuous-wave D-E was
carried out including two-dimensional measurements.
To obtain the maximum velocity across the homograft
(VAO), continuous Doppler was used from different transducer
positions. The flow velocity in the left ventricular outflow tract
(VLVOT) was recorded with pulsed Doppler from the apical
view, approximately one cm proximal to the aortic prosthesis,
before acceleration of the flow occurred. Maximum (DPmax)
and mean (DPmean) Doppler-derived pressure differences were
calculated from VAO using the short [DP 5 4 3 VA
2
O] and the
long form [DP 5 4 3 (VA
2
O 2 VL
2
VOT)] of the modified
Bernoulli equation (14). The effective orifice area (EOA),
stroke volume (SV), cardiac output (CO) and aortic valve
volume flow (AVF 5 SV/Systolic Ejection Period) were cal-
culated (15). Ejection fraction (EF) was determined using the
Simpson rule (16). Aortic regurgitation was estimated as trivial
(grade I), mild (grade II) moderate (grade III) and severe
(grade IV), based on the information from color flow mapping,
pulsed-wave Doppler and continuous-wave Doppler (17–19).
All measurements are presented as the average of three
consecutive cardiac cycles in patients with sinus rhythm and
five consecutive cycles in patients with atrial fibrillation. Mea-
surements and calculations, including the grading of AR, were
made on-line, with the operator unaware of the results of
previous examinations.
Exercise echocardiography. At a mean follow-up of 7
months, 31 of the patients, with a median valve size of 21 mm,
performed a symptom-limited supine bicycle exercise test. For
this purpose, we used a special bicycle ergometer with a
possibility of left lateral tilt to facilitate ultrasound measure-
ments (Ergoline GmbH & Co KG, Bitz, Germany). The initial
workload was 20 or 30 W depending on age, sex and fitness.
The work load was increased in steps by 10 or 20 W every
3 min. The exercise test was interrupted at perceived exertion
grade 7/10, according to the Borg scale (20). Heart rate and
Doppler recordings across the aortic prosthesis and in the left
ventricular outflow tract were obtained during the last minute
at each level of work load, using the same acoustic windows as
for the rest studies. Ten good-quality Doppler curves were
traced at each load and the measurements were averaged. The
diameter of the left ventricular outflow tract at rest was used to
calculate SV during exercise. Valve area index (EOA at
rest/BSA) was calculated for all patients undergoing exercise
and a prosthesis-patient mismatch was considered present
when values ,1cm2/m2 were obtained (21). Calculations from
exercise studies were made off-line from videotapes using the
same equipment and the same software as for resting studies.
The coefficients of variation for inter- and intraobserver
measurement variability for the experienced operators at our
laboratory have been reported earlier and are 2.0% and 2.1%
for aortic velocity measurements at rest and 2.0% and 1.9% for
aortic velocity measurements during exercise. For measure-
ment of LVOT diameter the corresponding values are 3.9%
and 2.8%, respectively (22). Intraobserver variability for grad-
ing of AR was assessed in 39 registrations chosen at random,
with excellent agreement according to Kappa statistics (Kappa
Abbreviations and Acronyms
AR 5 aortic regurgitation
D-E 5 Doppler echocardiography
NYHA 5 New York Heart Association
DPmax 5 maximum pressure difference
DPmean 5 mean pressure difference
EF 5 ejection fraction
EOA 5 effective orifice area
CO 5 cardiac output
AVF 5 aortic valve volume flow
BSA 5 body surface area
VAO 5 velocity across the aortic homograft
VLVOT 5 velocity in the left ventricular outflow tract
1003JACC Vol. 32, No. 4 ERIKSSON ET AL.
October 1998:1002–8 HEMODYNAMICS OF AORTIC HOMOGRAFT VALVES
value 0.92 6 0.05SE). Disagreement in grading of AR between
the two blinded readings occurred in two cases and regarded
only AR grade I and II.
Statistics. Continuous data are presented as mean and one
standard deviation (SD). The Kaplan-Meier product limit
estimate of survivor function was employed to calculate the
actuarial incidence of postoperative aortic homograft regurgi-
tation (23). Three patients who developed AR grade III/IV
were reoperated on and then censored from further survival
analysis. The instantaneous risk of aortic regurgitation was
described with the hazard function (24). One-way analysis
of variance (ANOVA) was used to study the difference in
Doppler-derived variables between patients divided according
to valve size. When the F-value revealed a significant differ-
ence, the means were compared with Scheffe’s test. Two-way
ANOVA for repeated measures, paired or unpaired t test and
regression analyses were used where appropriate. A p value
,0.05 was considered as significant.
Results
There was no mortality during a median clinical follow-up
time of 28 months (range 4–54). One 81-year-old patient
suffered a minor stroke 30 days after the operation. There was
no evidence of endocarditis in any patient, although 1 patient
was treated for septicaemia. Three patients deteriorated dur-
ing follow-up from NYHA functional class I to class III due to
AR grade III or IV and required reoperation. At the most
recent follow-up, 54 of the remaining 56 patients (96%) were
in NYHA class I or II and 2 patients were in class III. Overall
freedom from reoperation was 94%.
Homograft valve regurgitation. The median echocardio-
graphic follow-up was 25 months (range 4–50). In 6 patients
(10%), AR grade I was demonstrated by D-E 1 week after the
operation. During follow-up AR increased in severity to grade
II-IV in 5 of these 6 patients and necessitated reoperation in
two cases. Actuarial analysis of freedom from AR more than
grade I, II and III, respectively, is shown in Figure 1. During
follow-up, AR grade II or more was detected in 25% (15/59) of
the patients. The hazard function showed a time-related
increasing risk of developing AR, which at two years was 1.7
for AR grade I or more, 0.4 for grade II or more and 0.06 for
AR grade III or more (Fig. 2).
To study the hemodynamic effect of AR grade II, the left
ventricular end-diastolic diameter (LVD) and systolic function
were analyzed. LVD at the most recent follow-up was 4.8 (0.6)
cm in patients with AR grade II (n 5 12) and 4.7 (0.4) cm in
AR grade 0-I (n 5 44). LVD did not change significantly
during follow-up within the groups. The mean difference in
LVD from 1-week examination to the most recent follow-up
was 0.16 (0.5) cm in patients with AR grade II and 20.10 (0.6)
cm in those with AR grade 0-I (p 5 0.19). There was no
significant change in EF during follow-up in any of the groups.
Reoperations. The 3 patients who developed regurgitation
grade III or IV were uneventfully reoperated on at 4, 18, and
26 months, respectively, with implantation of a mechanical
prosthesis. In one of these patients the 23-mm homograft
suddenly failed 4 months after implantation and required valve
explantation. Small fenestrations were observed at the coapta-
tion zones of the leaflets which might have caused leaflet
prolapse. In the second and third patients (valve size 18 mm
and 21 mm), AR progressed during the first and second
postoperative year due to prolapse of the left and noncoronary
cusps, respectively. On reoperation, no macroscopic signs of
structural degeneration of the homografts were seen. Micro-
scopic examination revealed nonspecific degenerative tissue
Figure 1. Actuarial analysis of freedom from postop-
erative aortic regurgitation (AR) more than grade I, II
and III, respectively, in 59 patients with a cryopre-
served aortic homograft valve. Numbers of patients at
risk and 95% confidence limits are indicated.
1004 ERIKSSON ET AL. JACC Vol. 32, No. 4
HEMODYNAMICS OF AORTIC HOMOGRAFT VALVES October 1998:1002–8
changes with fissures and splitting of elastic fibers in all three
explanted homograft valves.
Hemodynamics at rest. Hemodynamic findings at a mean
follow-up of 7 months were compared with those at one week
(Table 1). Stroke volume was significantly higher at the
follow-up. There was no significant change in EF, EOA or CO,
while heart rate, DPmax and DPmean decreased slightly during
the same period. Doppler-derived variables for all valve sizes
at 7 months follow-up are presented in Table 2. EF and CO
were similar in all groups. There was a significant negative
correlation between DPmax and valve size (p , 0.01, r 5
20.37). However, a considerable overlap in pressure differ-
ences across the prostheses existed between the four groups of
valve sizes, and a statistically significant difference in DPmax
and DPmean was found only between 17–19 mm valves and
22–23 mm valves. The group with 17–19 mm valves also
differed significantly from all other sizes regarding EOA.
Hemodynamics during exercise. We obtained satisfactory
Doppler recordings in all the 31 patients. All but 2 patients had
sinus rhythm. Median achieved workload during the symptom-
limited supine exercise test was 60 W (range 30–150). In 28
patients exercise capacity was limited by leg fatigue and in
three by dyspnoea. None of the patients developed chest pain.
Hemodynamic changes during exercise are presented in Table
3. The increase in CO was effected mainly by an increase in
heart rate by 59% and a smaller, but significant, increase in
stroke volume by 7%. DPmax and DPmean, calculated with the
short form of the Bernoulli equation, increased by 6.6 mm Hg
and 3.0 mm Hg, respectively, during exercise (p , 0.001 versus
rest). EOA did not change significantly.
Figure 2. Instantaneous postoperative risk of develop-
ing aortic regurgitation (AR) more than grades I, II and
III, respectively, in 59 patients with cryopreserved aor-
tic homograft valves.
Table 1. Aortic Homograft Valves: Hemodynamic Results in 57*
Patients 1 Week and 7 Months Postoperatively
Variable 1 week 7 months p Valve
Heart rate (beat/min) 79 (13) 72 (14) , 0.01
LVD (cm) 4.8 (0.6) 4.7 (0.5) NS
Ejection fraction (%) 60 (14) 60 (9) NS
Stroke volume (mL) 60.7 (13.4) 68.0 (13.0) , 0.001
Cardiac output (L/min) 4.7 (1.1) 4.8 (1.0) NS
Maximum velocity LVOT (m/s) 1.0 (0.14) 0.95 (0.14) NS
Maximum velocity Ao (m/s) 1.8 (0.4) 1.7 (0.3) , 0.01
DPmax (mm Hg) 13.2 (6.2) 11.4 (4.6) , 0.001
DPmax† (mm Hg) 9.1 (5.9) 7.7 (3.9) , 0.001
DPmean (mm Hg) 6.8 (3.1) 5.5 (2.1) , 0.001
DPmean† (mm Hg) 4.5 (2.8) 3.5 (1.8) , 0.001
Effective orifice area (cm2) 2.1 (0.6) 2.1 (0.5) NS
Values are shown as mean (one SD). *One reoperated patient was excluded
and another was unable to come to both examinations. Ao 5 aorta; LVD 5 left
ventricular end-diastolic diameter; LVOT 5 left ventricular outflow tract. DPmax
and DPmean 5 maximum and mean pressure differences calculated with the short
and the long (†) form of the Bernoulli equation.
Table 2. Aortic Homograft Valves: Results by Annulus Diameter in
57* patients 7 Months Postoperatively
Variable
Valve size
17–19 mm
(n 5 16)
20–21 mm
(n 5 22)
22–23 mm
(n 5 12)
24–27 mm
(n 5 7)
BSA (m2) 1.7 (0.2) 1.9 (0.2) 2.0 (0.2) 2.0 (0.2)
Ejection fraction (%) 63 (9) 59 (10) 53 (9) 64 (6)
Cardiac output (L/min) 4.5 (0.8) 5.0 (0.9) 4.5 (1.5) 5.6 (1.0)
DPmax (mm Hg) 13.9 (4.7) 11.8 (4.4) 8.7 (3.7) 9.4 (3.3)
DPmax† (mm Hg) 9.7 (4.2) 7.9 (4.0) 5.6 (3.1) 6.2 (2.6)
DPmean (mm Hg) 6.5 (2.0) 5.6 (2.3) 4.2 (1.6) 4.7 (1.5)
DPmean† (mm Hg) 4.2 (1.8) 3.6 (2.0) 2.6 (1.4) 2.8 (1.1)
Effective orifice area (cm2) 1.7 (0.3) 2.3 (0.4) 2.5 (0.3) 2.7 (0.3)
Values are shown as mean (one SD). *One reoperated patient was excluded
and another was unable to come to the examination. DPmax and DPmean 5
maximum and mean pressure differences calculated with the short and the long
(†) form of the Bernoulli equation.
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Eight of the 31 patients studied during exercise fulfilled the
criterion for prosthesis-patient mismatch (valve area index
range 0.76–0.98 cm2/m2). Homograft sizes in these eight
patients ranged from 18 mm to 24 mm. There were 2 patients
with an 18-mm valve, 2 with a 19-mm valve, 2 with a 21-mm, 1
with a 22-mm valve and 1 with a 24-mm valve. The difference
between the annulus size of the patient and the homograft
annulus size did not differ significantly (p 5 0.2) between the
group with “mismatch” (mean difference 1.6 6 0.5 mm) and
without “mismatch” (mean difference 2.0 6 0.9 mm). Further-
more, the two groups did not differ regarding EF, CO, AVF or
achieved workload. The “mismatch” group showed signifi-
cantly higher pressure differences at rest (p , 0.001) and at
peak exercise (p , 0.001), and a significantly higher increase of
DPmax during exercise than the group without “mismatch”
(Fig. 3). There was a significant interaction according to
two-way ANOVA between the groups and the effect of exer-
cise (F(1,29) 5 21.2, p , 0.001). The difference in DPmax,
calculated with both forms of the Bernoulli equation, between
the two groups was significant even after adjustment for
differences in homograft valve sizes (p , 0.001 at rest, p ,
0.001 at peak exercise).
Discussion
This study confirmed all recognized advantages of aortic
valve replacement with cryopreserved aortic homograft valves,
demonstrating the low incidence of thromboembolic events
and homograft endocarditis, and low pressure differences
across the valves at rest and during exercise. There was no
mortality in this series despite the complexity of the valve
insertion technique in combination with 41% concomitant
procedures and the older age of our patients than of those in
other studies (3–9,11). However, this echocardiographic
follow-up also showed that the incidence and severity of AR
increased significantly during midterm follow-up and 3 patients
required reoperation for severe AR within 26 months of the
primary operation.
Homograft valve regurgitation. Generally, most studies of
cryopreserved aortic homografts report excellent results re-
garding freedom from reoperation due to structural valve
deterioration, being 85% at 8 years (6) and 80% at 15 years (4).
However, the reported incidence and severity of postoperative
AR in patients with cryopreserved aortic homografts varies
among different reports due to methods and length of follow-
up, studied population and surgical technique (3–9,11). In
previous mid- and long-term studies, AR was assessed by
clinical examination (3,4), auscultation (5) or, in most recent
studies, with D-E (6–9,11). AR detected by typical cardiac
diastolic murmur was present in 45% of the patients with
homografts at 7.5 years follow-up (5). Progressive severe AR
showed with D-E was first described by Daicoff et al in a small
number of young patients with freehand aortic homografts (8).
Using serial D-E, which is a very sensitive method for detection
and monitoring of AR, we demonstrated that also the propor-
tion of patients with AR grade I and II increased significantly
during midterm follow-up, even if the valves were perfectly
competent early after the operation. Although 61% of patients
developed AR grade I or II during follow-up, all of them
remained clinically stable in NYHA class I or II. Patients with
AR grade II were further analyzed with special regard to the
left ventricular performance, but we could not demonstrate
any significant change in left ventricular dimension or EF.
However, the importance of mild AR for long-term results
regarding valve durability and left ventricular function is still to
be assessed. For that reason further long-term D-E studies
seem mandatory.
Early and late outcome of homograft aortic valve replace-
ment may be influenced by the method of implantation. When
the subcoronary implantation technique is used there is a risk
of malalignment of commisures or distortion of sinotubular
geometry resulting in AR postoperatively. Root replacement
and the inclusion cylinder techniques have been shown to
reduce the incidence of postoperative AR. Dearani et al.
observed a 26% risk for developing AR grade III at 7 years
with the use of subcoronary technique compared to 12% risk
Table 3. Aortic Homograft Valves: Results at Rest and at Peak
Symptom-limited Supine Exercise in 31 Patients
Variable Rest Exercise p Value
Heart rate (beat/min) 71 (10) 113 (20) , 0.001
Systolic blood pressure (mm Hg) 139 (21) 184 (33) , 0.001
Stroke volume (mL) 67.8 (13.8) 72.5 (14.2) , 0.01
Cardiac output (L/min) 4.7 (0.9) 8.1 (2.1) , 0.001
Maximum velocity LVOT (m/s) 0.9 (0.1) 1.1 (0.2) , 0.001
Maximum velocity Ao (m/s) 1.7 (0.3) 2.1 (0.5) , 0.001
Aortic valve volume flow (ml/s) 227 (40) 280 (64) , 0.001
DPmax (mm Hg) 11.9 (5.2) 18.5 (9.5) , 0.001
DPmax† (mm Hg) 8.2 (4.3) 13.4 (8.6) , 0.001
DPmean (mm Hg) 5.7 (2.4) 8.7 (4.5) , 0.001
DPmean† (mm Hg) 3.8 (1.9) 6.0 (3.9) , 0.001
Effective orifice area (cm2) 2.2 (0.5) 2.2 (0.5) NS
Values are shown as mean (one SD). Ao 5 aorta; LVOT 5 left ventricular
outflow tract; DPmax and DPmean 5 maximum and mean pressure differences
calculated with the short and the long (†) form of the Bernoulli equation.
Figure 3. Maximum pressure differences (DPmax, calculated with the
short form of the modified Bernoulli equation) at rest and during
exercise in eight patients with prosthesis-patient mismatch (valve area
index ,1 cm2/m2, F) and in 23 patients with valve area index $1
cm2/m2 (). Mean and one SD are indicated.
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when the homograft was implanted as a cylinder (11). An
excellent freedom from significant AR in homografts im-
planted as an inclusion cylinder or as free-standing root
replacement has earlier been reported by Knott-Craig et al.
(25). However, similar results have been reported in a series of
subcoronarily implanted homografts, with 85% freedom from
AR at 8 years (6). Despite selection of patients with symmetric
aortic roots and general avoidance of homograft implantation
if the host annular diameter was larger than 27 mm, we found
progression of AR during midterm follow-up. The experience
from this study has resulted in more restrictive use of subcoro-
narily implanted homografts at our institution; root replace-
ment now being the preferred technique.
Rest and exercise hemodynamics. The anatomy and func-
tion of the aortic annulus and coronary sinuses normally
dampen the mechanical stress to which the aortic leaflets are
subjected during the cardiac cycle (26). As the role of the
aortic base and the central flow pattern are preserved by the
use of subcoronary implantation, a better hemodynamic profile
might be expected both at rest and during exercise. These
expectations were fully confirmed in this study, demonstrating
low maximum and mean pressure differences in all valve sizes
even though 39/59 (66%) of our patients had small aortic roots
and received homograft sizes #21 mm. During exercise with an
increase in CO by 72% the DPmean increased only slightly, from
5.7 to 8.7 mm Hg. EOA remained unchanged during exercise
for all valve sizes, suggesting that EOA is a flow-independent
parameter.
The pressure differences in our study were much lower than
those reported earlier for most stented bioprostheses and
mechanical valves (27,28), demonstrating the excellent hemo-
dynamic properties of aortic homografts. In the literature so
far, only limited data are available regarding D-E evaluation of
homograft valves (19,29,30). The only previous study dealing
with exercise hemodynamics of homografts was performed
with D-E 30 s after a symptom-limited supine exercise test in
27 normally functioning 20–22 mm homograft valves (30). The
low pressure differences found, both at rest and after exercise,
were similar to our results.
Since it is known that the short form of the modified
Bernoulli equation may lead to overestimation of pressure
differences at increased flow rates during exercise (27), we also
used the long form of the modified Bernoulli equation, in
which the velocity in LVOT is taken into consideration.
However, in this study of valves with low pressure differences,
the short form of the Bernoulli equation resulted in only
slightly higher DPmax, by 3.7 (1.1) mm Hg at rest and 5.1 (1.5)
mm Hg at peak exercise. Similarly, for DPmean the mean
difference between the values calculated with the short the
long form of the Bernoulli equation, respectively, was 1.9 (0.6)
mm Hg at rest and 2.7 (1.0) mm Hg at peak exercise (Table 3).
Prosthesis-patient mismatch. Prosthesis-patient mismatch
is present when EOA of the prosthesis is less than that of the
patient’s native valve and can be associated with high postop-
erative transvalvular pressure gradients (31). To avoid mis-
match of hemodynamic importance, the valve area index
should be at least 1 cm2/m2 (21). Although the same criteria for
homograft selection were used for all patients preoperatively
and there was no indication at operation that the homograft
was too small, prosthesis-patient mismatch was observed in 8
patients with different homograft sizes. We do not believe that
our suture technique caused the constriction as isolated su-
tures were used for proximal suture line. In the present study,
patients with mismatch had significantly higher pressure dif-
ferences than those with valve area index $1 cm2/m2. During
exercise transvalvular velocities increased in all 31 patients,
confirming that Doppler-derived pressure gradients, in con-
trast to what was shown for EOA, are flow-dependent (22).
Our results with D-E during exercise in patients with a low
valve area index suggest that the mismatch-situation accentu-
ates this flow-dependence, with more marked increases in
pressure gradients during exercise (Fig. 3). The concept of
prosthesis-patient mismatch earlier described for small biolog-
ical prostheses (32) but not for homografts also seems valid for
homograft valves and probably accounts for higher pressure
gradients in these patients. In our study, DPmax . 35 mm Hg
during exercise was found only in patients with valve area
index , 1 cm2/m2 (n 5 3, see Fig. 3). The midterm results
regarding progression of AR or left ventricular systolic func-
tion in this study were not influenced by the mismatch situa-
tion.
Conclusions. Aortic valve replacement with cryopreserved
subcoronarily implanted homograft can be performed safely
with good clinical results. Aortic valve homograft as a valve
substitute in patients with indication for a tissue prosthesis has
a beneficial hemodynamic profile with low pressure differences
at rest and during exercise also in patients with narrow aortic
roots. Higher pressure differences were measured in the few
patients with prosthesis-patient mismatch. AR grade I or II
were often detected during follow-up of patients with aortic
homografts. As the regurgitation progresses with time we
would stress the importance of Doppler echocardiographic
follow-up of these patients. In addition to studies at rest,
exercise echocardiography provides further insight into valve
hemodynamics, especially when prosthesis-patient mismatch is
suspected.
We are grateful to Viveka Rendelius for her skillful assistance with Doppler-
echocardiography studies.
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